Meeting
2024 ASCO Quality Care Symposium
Evaluating enrollment processes and eligibility criteria of manufacturer free-drug patient assistance programs for oral anticancer agents used in hematologic malignancies.
Presenter
Benyam Muluneh, PharmD
Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Access to Treatment
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 117)
DOI
10.1200/OP.2024.20.10_suppl.117
Abstract #
117
Poster Bd #
C15
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Quality Care Symposium
A prospective, longitudinal study of health-related quality of life and contributing factors and its impact on medication adherence to oral anticancer agents in real-world patients with leukemia.
Speaker: Benyam Muluneh, PharmD
Videos & Slides
2024 ASCO Annual Meeting
Data-driven strategies for enhancing diversity in oncology clinical trials: Optimization of eligibility criteria.
Speaker: Corey M. Benedum, PhD, MPH
Videos & Slides
2024 ASCO Annual Meeting
Impact of trial eligibility criteria on enrollment to KRASG12C inhibitor trials in patients with non-small cell lung cancer.
Speaker: Michael S. May, MD
Speaker: Panel Discussion